Invention Grant
- Patent Title: High affinity anti-GD2 antibodies
-
Application No.: US14776298Application Date: 2014-03-14
-
Publication No.: US10167341B2Publication Date: 2019-01-01
- Inventor: Nai-Kong V. Cheung , Mahiuddin Ahmed , Qi Zhao
- Applicant: Memorial Sloan-Kettering Cancer Center
- Applicant Address: US NY New York
- Assignee: Memorial Sloan Kettering Cancer Center
- Current Assignee: Memorial Sloan Kettering Cancer Center
- Current Assignee Address: US NY New York
- Agency: Choate, Hall & Stewart, LLP
- Agent Brenda Herschbach Jarrell; Tracy L. Vrablik
- International Application: PCT/US2014/029308 WO 20140314
- International Announcement: WO2014/144763 WO 20140918
- Main IPC: C07K16/00
- IPC: C07K16/00 ; C07K16/30 ; A61K51/10 ; A61K47/68
Abstract:
In this application are described high affinity anti-GD2 antibody agents, and various methods and reagents related thereto, including for example for the detection, prevention, and/or therapeutical treatment of GD2-related diseases, in particular, neuroblastoma.
Public/Granted literature
- US20160032009A1 HIGH AFFINITY ANTI-GD2 ANTIBODIES Public/Granted day:2016-02-04
Information query
